Paracetamol
Acute symptom relief in selected attacks.
View uses, evidence and experiences →Understand the main options used in Australia, what they are designed to do and where they usually sit in the care pathway. This is a directory for better conversations, not a treatment recommendation.
Suitability depends on your migraine pattern, other conditions, pregnancy status, interactions, previous treatment and individual risk.
Frequency and symptoms can overlap: someone can have chronic migraine and vestibular symptoms, for example. Choose a label to explore usual roles, not to select a treatment for yourself.
General information, not personal medical advice. Some uses are off-label or supported by limited evidence. TGA approval, PBS eligibility and individual suitability differ. Do not start, stop or change treatment without your clinician or pharmacist.
58 treatment profiles in Clea. Directory order is not a ranking of effectiveness.
Acute symptom relief in selected attacks.
View uses, evidence and experiences →Acute treatment for selected migraine attacks.
View uses, evidence and experiences →Acute treatment and sometimes short-term strategies discussed by clinicians.
View uses, evidence and experiences →Acute treatment in selected adults.
View uses, evidence and experiences →Migraine-specific acute treatment.
View uses, evidence and experiences →Migraine-specific acute treatment.
View uses, evidence and experiences →Migraine-specific acute treatment.
View uses, evidence and experiences →Migraine-specific acute treatment.
View uses, evidence and experiences →Migraine-specific acute treatment.
View uses, evidence and experiences →Migraine-specific acute treatment and, under approved conditions, prevention.
View uses, evidence and experiences →Preventive treatment for eligible adults.
View uses, evidence and experiences →Nausea/vomiting support and sometimes part of acute migraine care.
View uses, evidence and experiences →Nausea and vertigo symptom support in selected situations.
View uses, evidence and experiences →Nausea support in selected people.
View uses, evidence and experiences →Established non-migraine-specific preventive option.
View uses, evidence and experiences →Established preventive option.
View uses, evidence and experiences →Established preventive option.
View uses, evidence and experiences →Established migraine preventive.
View uses, evidence and experiences →Established preventive used particularly when sleep or pain factors coexist.
View uses, evidence and experiences →Preventive option used in selected people.
View uses, evidence and experiences →Preventive option in selected people.
View uses, evidence and experiences →Preventive option used selectively.
View uses, evidence and experiences →Older migraine preventive option.
View uses, evidence and experiences →Preventive option used in some countries and specialist contexts.
View uses, evidence and experiences →Migraine-specific preventive therapy.
View uses, evidence and experiences →Migraine-specific preventive therapy.
View uses, evidence and experiences →Migraine-specific preventive therapy.
View uses, evidence and experiences →Migraine-specific preventive therapy.
View uses, evidence and experiences →Preventive treatment for selected chronic migraine patients.
View uses, evidence and experiences →Short-term or bridging option in selected headache settings.
View uses, evidence and experiences →Procedure discussed in selected headache services.
View uses, evidence and experiences →Sometimes used when myofascial pain coexists with headache.
View uses, evidence and experiences →Non-invasive neuromodulation option for acute and/or preventive use depending device mode.
View uses, evidence and experiences →Wearable neuromodulation used for migraine in markets where available.
View uses, evidence and experiences →Neuromodulation option used for some headache disorders in selected markets.
View uses, evidence and experiences →Non-invasive head-worn neuromodulation in markets where available.
View uses, evidence and experiences →Non-invasive neuromodulation for selected migraine indications.
View uses, evidence and experiences →Supplement sometimes used as part of prevention.
View uses, evidence and experiences →Supplement used in migraine prevention.
View uses, evidence and experiences →Supplement sometimes used for migraine prevention.
View uses, evidence and experiences →Sometimes discussed when sleep disturbance and migraine coexist.
View uses, evidence and experiences →Non-drug preventive/supportive approach.
View uses, evidence and experiences →Helps with coping, disability, stress and behavioural migraine management.
View uses, evidence and experiences →Teaches awareness/control of physiological responses.
View uses, evidence and experiences →Stress-regulation and symptom-management support.
View uses, evidence and experiences →Supports coping, stress regulation and quality of life.
View uses, evidence and experiences →Regular graded activity may support prevention and general health.
View uses, evidence and experiences →Used for persistent dizziness, motion sensitivity and balance problems in selected people.
View uses, evidence and experiences →Regular sleep/wake timing can reduce avoidable migraine threshold changes.
View uses, evidence and experiences →Avoiding long gaps between meals can help some people maintain a steadier migraine threshold.
View uses, evidence and experiences →Maintaining adequate fluid intake can reduce dehydration-related headache burden.
View uses, evidence and experiences →Useful when diet is complicated by nausea, restrictive eating, gastrointestinal issues or suspected food patterns.
View uses, evidence and experiences →May help when musculoskeletal or movement factors coexist with migraine.
View uses, evidence and experiences →Supports coping, mood, disability, sleep and adjustment to chronic illness.
View uses, evidence and experiences →Helps adapt work, study, routines and environments around disability.
View uses, evidence and experiences →Supports graded exercise and confidence where migraine, deconditioning or comorbidity complicate activity.
View uses, evidence and experiences →Improves understanding of migraine, treatment roles, tracking and self-management.
View uses, evidence and experiences →Helps people organise history, identify appropriate care pathways and prepare for appointments.
View uses, evidence and experiences →Use labels are an editorial guide to the cited sources, not a clinical recommendation or an independent clinical-review badge. Each profile retains its separate review status.
Used during an attack to reduce pain, nausea and associated symptoms.
Often first-line options when appropriate
Sumatriptan, rizatriptan, eletriptan, zolmitriptan, naratriptan
TGA-approved for acute migraine in adults
Metoclopramide, domperidone or prochlorperazine may be used in selected people
Used regularly to reduce attack frequency, severity and overall migraine burden.
Examples include propranolol, metoprolol and candesartan
Examples include topiramate; sodium valproate is used selectively and has major pregnancy restrictions
Examples include amitriptyline, nortriptyline and venlafaxine
TGA-approved for adults with at least four migraine days per month
TGA-approved for prevention of episodic migraine in eligible adults
Migraine-specific medicines that block CGRP or its receptor.
Injection; PBS criteria apply
Injection; PBS criteria apply
IV infusion; PBS-listed for chronic migraine under current criteria
Available by private prescription according to Migraine & Headache Australia
Oral options with different approved uses
Options usually considered through a clinician or specialist service.
Established preventive option for selected chronic migraine
May be offered by headache specialists in selected situations
Non-invasive nerve stimulation; availability and evidence differ by device
Can support selected people with motion-induced dizziness or imbalance
Usually used alongside medical care rather than as a substitute for it.
Regularity can reduce avoidable threshold changes
Regular aerobic activity can help some people when introduced gradually
Commonly discussed preventive supplements with varying evidence
Can improve coping, stress regulation and migraine-related disability
May help some people and is included among migraine prevention options by healthdirect
Acute treatments are used during an attack to reduce pain and associated symptoms. Options include simple analgesics, triptans, gepants and anti-nausea medicines.
Triptans are migraine-specific acute medicines. Several are available in Australia in different formulations.
Gepants block the CGRP receptor. In Australia, rimegepant is approved for acute and preventive use in adults, while atogepant is approved for migraine prevention in adults with at least four migraine days per month.
Preventive treatment aims to reduce how often migraine occurs, how severe attacks are and how much migraine disrupts life.
Many established migraine preventives were originally developed for blood pressure, epilepsy or mood conditions.
CGRP-targeting monoclonal antibodies are migraine-specific preventive treatments given by injection or infusion.
OnabotulinumtoxinA is an established preventive option for selected people with chronic migraine and is administered by trained clinicians.
Nausea and vomiting can be major parts of a migraine attack. Anti-nausea medicines can be used alone or alongside other acute treatments.
Magnesium, riboflavin (vitamin B2) and coenzyme Q10 are commonly discussed nutraceutical options for migraine prevention.
Non-invasive neuromodulation devices stimulate specific nerves or brain pathways and can be used for acute or preventive migraine treatment in selected people.
Vestibular rehabilitation can help selected people with motion-induced dizziness, balance problems and visual-motion sensitivity.
Behavioural and psychological strategies can reduce stress-related amplification, improve coping and support migraine management alongside medical care.
A practical, evidence-informed guide to paracetamol for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to ibuprofen for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to naproxen for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to aspirin for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to sumatriptan, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to rizatriptan, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to eletriptan, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to zolmitriptan, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to naratriptan, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to rimegepant, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to atogepant, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to prochlorperazine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to metoclopramide, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to domperidone, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to candesartan, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to propranolol, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to metoprolol, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to topiramate, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to amitriptyline, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to nortriptyline, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to venlafaxine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to sodium valproate, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to fremanezumab (ajovy), what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to galcanezumab (emgality), what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to eptinezumab (vyepti), what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to erenumab (aimovig), what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to greater occipital nerve block, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to magnesium for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to riboflavin for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to coq10 for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to acupuncture for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to cbt for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to biofeedback for migraine, what it can mean for people living with migraine and what is worth discussing with a clinician.
A practical, evidence-informed guide to neuromodulation devices, what it can mean for people living with migraine and what is worth discussing with a clinician.
A medicine can be approved by the TGA without being subsidised on the PBS. PBS eligibility can also depend on diagnosis, migraine frequency, previous treatment trials and prescriber requirements. Always check the current official criteria.
Frequent use of acute medicines can contribute to medication overuse headache. Pregnancy, breastfeeding, cardiovascular disease, kidney or liver disease and medicine interactions can all change what is appropriate. Review your plan with a clinician or pharmacist rather than stacking treatments yourself.
Read about medication overuse headacheClea tracks new migraine medicines, PBS/TGA changes, evidence and practical access updates.
Clea can help organise your treatment history and find the relevant migraine care pathway.
Start with Clea